New results from the world’s largest ever study of diabetes treatments show that intensive blood glucose (sugar) control protects patients against serious complications of the disease. This in contrast to another study recently published, the ACCORD study, that indicated the opposite for certain patients. The results of the new study called ADVANCE was presented at the American Diabetes Association and published in the New England Journal of Medicine.

• Dr. Pavel Hamet, M.D., Ph.D., CSPQ, FRCP(C), Director of Research, Chief of Gene Medicine Services, Endocrinology Services and Director of the Laboratory of Molecular Medicine at Centre hospitalier de l’Université de Montréal (CHUM), Professor of Medicine at l’Université de Montréal, Adjunct Professor in the division of experimental medicine, Department of Medicine at McGill University He holds the Canada Research Chair in Predictive Genomics of Cardiovascular diseases and hypertension, a member of the Canadian Obesity Network and is the Canadian lead investigator and member of ADVANCE Management Committee